Synthesis of stable isotopically labelled internal standards for drug-drug interaction (DDI) studies

被引：0
|
作者：
Zimmermann, J. [1 ]
Allen, J. [2 ]
Atzrodt, J. [1 ]
De-Bruin, B. [2 ]
Derdau, V. [1 ]
Gantz, D. [1 ]
Herbert, J. [3 ]
Raddatz, S. [1 ]
Roy, S. [2 ]
机构：
[1] Sanofi Aventis, Global Isotope Chem & Metabollite Synthet Dept, D-65926 Frankfurt, Germany
[2] Sanofi Aventis, Global Isotope Chem & Metabollite Synthet Dept, F-91385 Chilly Mazarin, France
[3] Sanofi Aventis, Global Isotope Chem & Metabollite Synthet Dept, Ainwick NE66 2JH, England
来源：
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2007年 / 50卷 / 13-14期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1277 / 1278
页数：2
相关论文
共 50 条
  • [1] Synthesis of stable isotope labelled internal standards for drug-drug interaction (DDI) studies
    Atzrodt, J.
    Blankenstein, J.
    Brasseur, D.
    Calvo-Vicente, S.
    Denoux, M.
    Derdau, V.
    Lavisse, M.
    Perard, S.
    Roy, S.
    Sandvoss, M.
    Schofield, J.
    Zimmermann, J.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (18) : 5658 - 5667
  • [2] A survey of drug-drug interaction (DDI) studies.
    Marroum, P
    Burnett, A
    Svadjian, R
    Uppoor, RS
    Ajayi, F
    Yuan, R
    Lesko, LJ
    Balian, JD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 147 - 147
  • [3] Most common interactant drugs in drug-drug interaction (DDI) studies.
    Uppoor, RS
    Marroum, P
    Burnett, A
    Ajayi, F
    Yuan, R
    Svadjian, R
    Balian, JD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 147 - 147
  • [4] Role of in vitro metabolic interactions in the conduct of drug-drug interaction (DDI) studies.
    Yuan, R
    Balian, JD
    Svadjian, R
    Uppoor, RS
    Ajayi, F
    Burnett, A
    Lesko, LJ
    Marroum, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 218 - 218
  • [5] Drug-Drug Interaction (DDI) Due to the Inhibition of Fusidic Acid
    Shi, Yun
    LATIN AMERICAN JOURNAL OF PHARMACY, 2017, 36 (09): : 1736 - 1738
  • [6] Drug-Drug Interaction (DDI) of Eslicarbazepine Acetate with Antiepileptic Drugs
    Blum, David
    Nunes, Teresa
    Maier, Gary
    Versavel, Mark
    Zummo, Jacqueline
    Kharidia, Jahnavi
    Soares-da-Silva, Patricio
    NEUROLOGY, 2011, 76 (09) : A287 - A287
  • [7] Lung Cancer Drug-Drug Interaction (DDI) Related with Praeruptorin D
    Li, Ke
    Zhou, Ning
    LATIN AMERICAN JOURNAL OF PHARMACY, 2017, 36 (01): : 184 - 187
  • [8] Drug-drug interaction (DDI) potential of oral napabucasin in healthy adults
    Dai, Xiaoshu
    Karol, Michael D.
    Hitron, Matthew
    Hard, Marjie
    Goulet, Matthew T.
    Mclaughlin, Colleen F.
    Brantley, Scott J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [9] Use of simple stable labelled intermediates to produce complex isotopically labelled internal standards
    Allen, Paul
    Hickey, Mike
    Kingston, Lee
    Mather, Andrew
    Wilkinson, David J.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2007, 50 (5-6): : 590 - 592
  • [10] DDI-Transform: A neural network for predicting drug-drug interaction events
    Su, Jiaming
    Qian, Ying
    QUANTITATIVE BIOLOGY, 2024, 12 (02) : 155 - 163
12345